Introduction
Cancer pain remains one of the most challenging symptoms to manage in oncology, affecting more than 80% of patients with advanced-stage malignancies. While the World Health Organization (WHO) "three-step" analgesic ladder provides a foundational framework for pain management, it is not universally effective. Many patients experience "intractable" pain that does not respond adequately to standard pharmacological interventions. Furthermore, the long-term administration of high-dose opioids often results in debilitating side effects, such as gastrointestinal distress, sedation, and a significant decline in the patient's overall quality of life.
In response to these challenges, there is an increasing clinical interest in non-pharmacological interventions. Traditional Chinese Medicine (TCM) physical therapies, including acupuncture and acupoint embedding, have emerged as potential adjuncts to conventional care. This protocol outlines a systematic review and meta-analysis (registered under INPLASY202580066) designed to evaluate the clinical efficacy and safety of these TCM modalities specifically for moderate-to-severe cancer pain.
Methodology and Study Design
This study follows a rigorous protocol for a systematic review and meta-analysis of randomized controlled trials (RCTs). By synthesizing data from high-quality clinical trials, the researchers aim to provide a high-level evidence base for the integration of TCM into standard oncology practice.
Search Strategy and Data Sources
To ensure a comprehensive capture of relevant literature, the research team will perform an exhaustive search across nine major international and Chinese-specific databases:
- International Databases: PubMed, Medline, Science Direct, Google Scholar, Web of Science, and Embase.
- Chinese Databases: China National Knowledge Infrastructure (CNKI), VIP, CBM, and WanFang.
This dual-language approach is essential for TCM research, as it allows for the inclusion of a vast body of clinical evidence that may not be indexed in Western-centric medical databases.
Inclusion and Exclusion Criteria
The review will focus exclusively on RCTs involving patients diagnosed with moderate-to-severe cancer pain. The primary interventions under investigation include:
- Manual acupuncture
- Auricular point acupressure
- Acupoint catgut therapy (a technique involving the embedding of a "catgut" thread into specific acupoints for prolonged stimulation)
These therapies may be evaluated as monotherapies or in combination with standard Western medical treatments.
Statistical Analysis
Data synthesis will be conducted using RevMan 5.4 software. The researchers will employ a chi-square test to assess heterogeneity among the included studies. A fixed-effects model will be used if the $P$-value is $> 0.05$ (indicating low heterogeneity), while a random-effects model will be applied if the $P$-value is $\le 0.05$ to account for variations in study design and patient populations. Continuous variables will be reported as Weighted Mean Differences (WMDs) with 95% confidence intervals.
Outcome Measures
The meta-analysis will evaluate several key metrics to determine the holistic impact of TCM physical therapies:
- Pain Intensity: Measured primarily via the Numerical Rating Scale (NRS).
- Functional Status: Assessed using the Karnofsky Performance Status (KPS) score.
- Quality of Life (QOL): Evaluating the broader impact of pain relief on the patient's daily living and psychological well-being.
- Safety Profile: A systematic review of adverse reactions associated with TCM interventions.
- Opioid Sparing Effect: Monitoring the reduction in the dosage or frequency of conventional oral analgesics.
Discussion and Clinical Significance
The primary goal of this systematic review is to bridge the gap between traditional practices and evidence-based oncology. While organizations like the American Society of Clinical Oncology (ASCO) already recommend acupuncture for certain types of cancer pain, this study seeks to provide more granular data on its effectiveness for the most severe cases.
By including secondary outcomes like the mitigation of nausea, vomiting, and constipation, the study addresses the "double burden" faced by cancer patients: the pain itself and the side effects of its treatment. If the meta-analysis confirms that TCM physical therapies can effectively alleviate pain while reducing reliance on opioids, it will provide a strong clinical rationale for incorporating these non-drug interventions into global oncology care pathways.
Limitations
The authors acknowledge potential limitations, including the inherent heterogeneity of acupuncture techniques and the varying quality of reporting in original RCTs, particularly regarding patient dropout rates. These factors will be addressed through rigorous subgroup analyses and sensitivity testing to ensure the robustness of the final conclusions.
Protocol Registration: INPLASY202580066
Summary updated